|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.44 PLN | +1.26% |
|
-2.72% | -9.30% |
| 29/02 | Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Pharmena S.A. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was PLN 4.74 million compared to PLN 3.63 million a year ago. Net loss was PLN 0.155 million compared to PLN 0.171 million a year ago.
Basic loss per share from continuing operations was PLN 0.01 compared to PLN 0.02 a year ago. Diluted loss per share from continuing operations was PLN 0.01 compared to PLN 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.30% | 18.08M | |
| -0.68% | 264B | |
| +19.72% | 20.89B | |
| 0.00% | 19.67B | |
| +15.62% | 12.52B | |
| -14.17% | 9.53B | |
| +19.93% | 8.03B | |
| +10.20% | 6.01B | |
| -2.43% | 4.49B | |
| -13.55% | 4.01B |
PHARMENA S.A. 
